X-linked myotubular myopathy

被引:41
|
作者
Lawlor, Michael W. [1 ,2 ]
Dowling, James J. [3 ,4 ,5 ,6 ]
机构
[1] Med Coll Wisconsin, Dept Pathol & Lab Med, Milwaukee, WI USA
[2] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI USA
[3] Hosp Sick Children, Div Neurol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[4] Hosp Sick Children, Program Genet & Genome Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[5] Univ Toronto, Dept Paediat, Toronto, ON, Canada
[6] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
DYNAMIN; 2; MUSCLE; MUTATIONS; AUTOPHAGY; PHENOTYPE; PHOSPHATASES; INHIBITION; EXPRESSION; DEFICIENT; SPECTRUM;
D O I
10.1016/j.nmd.2021.08.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
X-linked myotubular myopathy (XLMTM) is a severe congenital muscle disease caused by mutation in the MTM1 gene. MTM1 encodes myotubularin (MTM1), an endosomal phosphatase that acts to dephosphorylate key second messenger lipids PI3P and PI3,5P2. XLMTM is clinically characterized by profound muscle weakness and associated with multiple disabilities (including ventilator and wheelchair dependence) and early death in most affected individuals. The disease is classically defined by characteristic changes observed on muscle biopsy, including centrally located nuclei, myofiber hypotrophy, and organelle disorganization. In this review, we highlight the clinical and pathologic features of the disease, present concepts related to disease pathomechanisms, and present recent advances in therapy development. (C) 2021 The Authors. Published by Elsevier B.V.
引用
收藏
页码:1004 / 1012
页数:9
相关论文
共 50 条
  • [41] X-linked myotubular myopathy:: anesthetic management for muscle biopsy
    Schmid, E
    Jöhr, M
    Berger, TM
    PEDIATRIC ANESTHESIA, 2006, 16 (02) : 218 - 220
  • [42] Gait characteristics in a canine model of X-linked myotubular myopathy
    Goddard, Melissa A.
    Burlingame, Emily
    Beggs, Alan H.
    Buj-Bello, Anna
    Childers, Martin K.
    Marsh, Anthony P.
    Kelly, Valerie E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 346 (1-2) : 221 - 226
  • [43] MORPHOLOGICAL AND MORPHOMETRIC ANALYSIS OF MUSCLE IN X-LINKED MYOTUBULAR MYOPATHY
    SILVER, MM
    GILBERT, JJ
    STEWART, S
    BRABYN, D
    JUNG, J
    HUMAN PATHOLOGY, 1986, 17 (11) : 1167 - 1178
  • [44] Mutation-specific therapy for X-linked myotubular myopathy
    Hayashi, S.
    Noguchi, S.
    Kumutpongpanich, T.
    Iida, A.
    Okubo, M.
    Matsuo, M.
    Nishino, I.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S79 - S79
  • [45] X-linked myotubular myopathy: Refinement of the critical gene region
    Smolenicka, Z
    Laporte, J
    Hu, L
    Dahl, N
    Fitzpatrick, J
    Kress, W
    LiechtiGallati, S
    NEUROMUSCULAR DISORDERS, 1996, 6 (04) : 275 - 281
  • [46] X-LINKED MYOTUBULAR MYOPATHY - CLINICAL AND PATHOLOGICAL FINDINGS IN A FAMILY
    OLDFORS, A
    KYLLERMAN, M
    WAHLSTROM, J
    DARNFORS, C
    HENRIKSSON, KG
    CLINICAL GENETICS, 1989, 36 (01) : 5 - 14
  • [47] X-linked myotubular myopathy: Report of a case with novel mutation
    Hortobagyi, Tibor
    Szabo, Hajnalka
    Kovacs, Krisztian S.
    Bodi, Istvan
    Bereg, Edit
    Katona, Marta
    Biancalana, Valerie
    Turi, Sandor
    Sztriha, Laszlo
    JOURNAL OF CHILD NEUROLOGY, 2007, 22 (04) : 447 - 451
  • [48] MTM1 mutations in X-linked myotubular myopathy
    Laporte, J
    Biancalana, V
    Tanner, SM
    Kress, W
    Schneider, V
    Wallgren-Pettersson, C
    Herger, F
    Buj-Bello, A
    Blondeau, F
    Liechti-Gallati, S
    Mandel, JL
    HUMAN MUTATION, 2000, 15 (05) : 393 - 409
  • [49] X-linked myotubular myopathy Living longer and awaiting treatment
    Finkel, Richard S.
    Darras, Basil T.
    NEUROLOGY, 2017, 89 (13) : 1316 - 1317
  • [50] X-linked myotubular myopathy in a family with three adult survivors
    Yu, S
    Manson, J
    White, S
    Bourne, A
    Waddy, H
    Davis, M
    Haan, E
    CLINICAL GENETICS, 2003, 64 (02) : 148 - 152